Trial Profile
A Randomized, Open-Label, Single-Dose, Two-Period Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Formulations of Vadadustat 150 mg Tablets
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2019
Price :
$35
*
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
- 27 Aug 2018 New trial record